Heparin Derivatives as Inhibitors of Heparanase from Metastatic Melanoma Cells
- 1 June 1989
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 556 (1), 496-498
- https://doi.org/10.1111/j.1749-6632.1989.tb22548.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Chemically modified heparins as inhibitors of heparan sulfate specific endo-.beta.-glucuronidase (heparanase) of metastatic melanoma cellsBiochemistry, 1986
- Effect of heparin modification on its circular dichroism spectrumBiochemical and Biophysical Research Communications, 1984
- Heparan Sulfate Degradation: Relation to Tumor Invasive and Metastatic Properties of Mouse B16 Melanoma SublinesScience, 1983
- Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin IIIBiochimica et Biophysica Acta (BBA) - General Subjects, 1977
- Heparin derivatives prepared by modification of the uronic acid carboxyl groupsThrombosis Research, 1972
- Conversion of carboxyl groups of mucopolysaccharides into amides of amino acid estersCarbohydrate Research, 1971